Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
Marcus Shaker, Giselle Mosnaim, John Oppenheimer, David R. Stukus, Elissa M. Abrams, Matthew Greenhawt
Topics & Concepts
MedicineIncremental cost-effectiveness ratioPandemicCost effectivenessCost-effectiveness analysisCase fatality rateHealth careCost–benefit analysisAllergen immunotherapyQuality-adjusted life yearMedical emergencyEnvironmental healthDiseaseAllergyRisk analysis (engineering)AllergenCoronavirus disease 2019 (COVID-19)ImmunologyInternal medicineInfectious disease (medical specialty)EconomicsEconomic growthPopulationBiologyEcologyAllergic Rhinitis and SensitizationPediatric health and respiratory diseasesFood Allergy and Anaphylaxis Research